Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ExQor Treatment Biologic
- Development stage
- Preclinical
- Lead developer
- ExQor Technologies
- Modality
- Recombinant Proteins and Enzymes
01
Overview
ExQor Treatment Biologic is an unnamed therapeutic protein delivery platform being developed by ExQor Technologies for the treatment of Alzheimer's disease and various forms of dementia. The biologic is designed to deliver restorative therapeutic proteins directly to damaged receptors within the brain's memory circuitry. Preclinical studies have reportedly demonstrated the drug's ability to reverse neurological damage, halt neurodegenerative progression, and restore learning and memory in animal models of Alzheimer's disease, HIV-associated neurodegeneration, and methamphetamine addiction. The therapeutic is being developed under a companion diagnostic framework, intended to follow a diagnostic biologic (an MRI contrast agent) through the regulatory process. It is currently in the IND-enabling phase of development.
- Other names
- Treatment BiologicTherapeutic protein delivery biologic
02
Targets
NTRK2 (Tropomyosin-related kinase receptor type B)
Beyond the preview
Go deeper on ExQor Treatment Biologic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExQor Treatment Biologic.